Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
7
|
11
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Cystadenoma, Mucinous
|
disease |
Neoplasms
|
Neoplastic Process
|
15
|
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Central corneal thickness
|
phenotype |
|
Clinical Attribute
|
35
|
61
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Cystadenoma
|
disease |
Neoplasms
|
Neoplastic Process
|
75
|
1
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Urinary Stress Incontinence
|
disease |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
79
|
5
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Cytokine Measurement
|
phenotype |
|
Laboratory Procedure
|
82
|
123
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Carpal Tunnel Syndrome
|
disease |
Nervous System Diseases; Wounds and Injuries
|
Disease or Syndrome
|
87
|
46
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Cardiovascular Abnormalities
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Congenital Abnormality
|
99
|
12
|
0.010 |
None |
< 0.001 |
1 |
|
2017 |
2017 |
Lean body mass
|
phenotype |
|
Clinical Attribute
|
144
|
211
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Mucinous Adenocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
159
|
10
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Physical Activity Measurement
|
phenotype |
|
Laboratory Procedure
|
160
|
355
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Osteoarthritis of hip
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
164
|
121
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Post MI
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
203
|
4
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Tonometry
|
phenotype |
|
Diagnostic Procedure
|
206
|
573
|
0.100 |
None |
1.000 |
3 |
3
|
2017 |
2018 |
Height
|
phenotype |
|
Organism Attribute
|
249
|
517
|
0.100 |
None |
1.000 |
3 |
3
|
2010 |
2013 |
Smoking Behaviors
|
phenotype |
Behavior and Behavior Mechanisms
|
Individual Behavior
|
249
|
742
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Transient Ischemic Attack
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
344
|
16
|
0.200 |
None |
1.000 |
1 |
|
2001 |
2001 |
Osteoarthritis, Knee
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
368
|
150
|
0.400 |
None |
1.000 |
2 |
3
|
2018 |
2019 |
Glomerulonephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
391
|
7
|
0.200 |
None |
1.000 |
1 |
|
2006 |
2006 |
Smoking
|
phenotype |
Behavior and Behavior Mechanisms
|
Individual Behavior
|
391
|
765
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Fibroid Tumor
|
disease |
Neoplasms
|
Neoplastic Process
|
413
|
14
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Malignant mesothelioma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
420
|
12
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Vital capacity
|
phenotype |
|
Clinical Attribute
|
430
|
746
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
522
|
|
0.200 |
None |
1.000 |
1 |
|
2007 |
2007 |
Uterine Fibroids
|
group |
Neoplasms
|
Neoplastic Process
|
569
|
154
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |